We see thunderstorms that sometimes produce tornadoes and many that also produce lighting. One recent Midwest thunderstorm decided to overachieve by doing both simultaneously.
We see thunderstorms that sometimes produce tornadoes and many that also produce lighting. One recent Midwest thunderstorm decided to overachieve by doing both simultaneously.
We see thunderstorms that sometimes produce tornadoes and many that also produce lighting. One recent Midwest thunderstorm decided to overachieve by doing both simultaneously.
UK scientists trial instant immunity antibody drug treatment for COVID-19 PTI
London: Scientists in the UK have begun trials of innovative antibody-drug treatments that they hope could provide instant protection against COVID-19.
The University College London Hospitals NHS Trust (UCLH) said that the researchers in the Storm Chase study believe a Long Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to the SARS-CoV-2 coronavirus and prevent them developing COVID-19.
The study, led by UCLH virologist Dr Catherine Houlihan, recruited the first participant in the world to the study earlier this month and has recruited 10 participants since then.
UK scientists trial AstraZeneca s instant immunity antibody-drug treatment for COVID-19
Tthe researchers in the Storm Chase study believe a Long-Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to coronavirus
PTI | December 27, 2020 | Updated 09:48 IST
AZD7442 has the potential to be an important preventative and therapeutic medicine against COVID-19
Scientists in the UK have begun trials of innovative antibody-drug treatments that they hope could provide instant protection against COVID-19.
The University College London Hospitals NHS Trust (UCLH) said that the researchers in the Storm Chase study believe a Long-Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to the SARS-CoV-2 coronavirus and prevent them developing COVID-19.